JP2020530765A5 - - Google Patents
Info
- Publication number
- JP2020530765A5 JP2020530765A5 JP2020502118A JP2020502118A JP2020530765A5 JP 2020530765 A5 JP2020530765 A5 JP 2020530765A5 JP 2020502118 A JP2020502118 A JP 2020502118A JP 2020502118 A JP2020502118 A JP 2020502118A JP 2020530765 A5 JP2020530765 A5 JP 2020530765A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- seq
- composition
- self
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762533312P | 2017-07-17 | 2017-07-17 | |
| US62/533,312 | 2017-07-17 | ||
| PCT/IB2018/055258 WO2019016680A1 (en) | 2017-07-17 | 2018-07-16 | ANTIGEN CONSTRUCTS OF LYSSAVIRUS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020530765A JP2020530765A (ja) | 2020-10-29 |
| JP2020530765A5 true JP2020530765A5 (enExample) | 2022-05-25 |
Family
ID=63364109
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020502118A Pending JP2020530765A (ja) | 2017-07-17 | 2018-07-16 | リサウイルス抗原構築物 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11278613B2 (enExample) |
| EP (1) | EP3655536A1 (enExample) |
| JP (1) | JP2020530765A (enExample) |
| CN (1) | CN111108203A (enExample) |
| BR (1) | BR112020000802A2 (enExample) |
| CA (1) | CA3070042A1 (enExample) |
| WO (1) | WO2019016680A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110269933A (zh) * | 2019-07-17 | 2019-09-24 | 苏州世诺生物技术有限公司 | 一种狂犬病毒亚单位疫苗的制备方法及其应用 |
| CN110643632B (zh) * | 2019-09-26 | 2022-06-10 | 中国科学院武汉病毒研究所 | 一种基于甲病毒复制子载体的狂犬病毒感染性克隆及制备方法和应用 |
| WO2022077330A1 (zh) * | 2020-10-15 | 2022-04-21 | 中国科学院深圳先进技术研究院 | 一种新型g基因及其在高效逆向跨单突触中的应用 |
| AU2022208435A1 (en) | 2021-01-18 | 2023-08-10 | Conserv Bioscience Limited | Coronavirus immunogenic compositions, methods and uses thereof |
| CN112961065B (zh) * | 2021-02-05 | 2023-03-14 | 嘉晨西海(杭州)生物技术有限公司 | 一种可电离脂质分子及其制备方法及其在制备脂质纳米颗粒的应用 |
| WO2022244815A1 (ja) * | 2021-05-19 | 2022-11-24 | 第一三共株式会社 | Ｈｐｖ感染症ワクチン |
| EP4396342A1 (en) | 2021-09-01 | 2024-07-10 | GlaxoSmithKline Biologicals S.A. | Plasmid dna purification methods |
| CN117460827A (zh) * | 2022-02-09 | 2024-01-26 | 苏州艾博生物科技有限公司 | 狂犬病核酸疫苗 |
| CN116120198B (zh) * | 2022-03-21 | 2024-03-15 | 苏州科锐迈德生物医药科技有限公司 | 具有甘油骨架的脂质化合物及基于其的脂质载体、核酸脂质纳米粒组合物和药物制剂 |
| CN116063410B (zh) * | 2022-10-20 | 2023-07-14 | 北京标驰泽惠生物科技有限公司 | 一种狂犬病毒g蛋白的突变体及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2139515T5 (pl) * | 2007-03-30 | 2024-04-08 | The Research Foundation Of The State University Of New York | Atenuowane wirusy przydatne w szczepionkach |
| CN105517569A (zh) * | 2013-08-21 | 2016-04-20 | 库瑞瓦格股份公司 | 狂犬病疫苗 |
| US10426737B2 (en) | 2013-12-19 | 2019-10-01 | Novartis Ag | Lipids and lipid compositions for the delivery of active agents |
| US10059655B2 (en) | 2013-12-19 | 2018-08-28 | Novartis Ag | Lipids and lipid compositions for the delivery of active agents |
| ES2969956T3 (es) | 2014-09-05 | 2024-05-23 | Novartis Ag | Lípidos y composiciones lipídicas para el suministro de agentes activos |
| JP7118062B2 (ja) | 2016-12-09 | 2022-08-15 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | リサウイルス抗原を有するチンパンジーアデノウイルス構築物 |
| GB201620968D0 (en) * | 2016-12-09 | 2017-01-25 | Glaxosmithkline Biologicals Sa | Adenovirus polynucleotides and polypeptides |
-
2018
- 2018-07-16 CN CN201880060285.4A patent/CN111108203A/zh active Pending
- 2018-07-16 WO PCT/IB2018/055258 patent/WO2019016680A1/en not_active Ceased
- 2018-07-16 BR BR112020000802-8A patent/BR112020000802A2/pt not_active Application Discontinuation
- 2018-07-16 JP JP2020502118A patent/JP2020530765A/ja active Pending
- 2018-07-16 EP EP18759392.6A patent/EP3655536A1/en not_active Withdrawn
- 2018-07-16 CA CA3070042A patent/CA3070042A1/en active Pending
- 2018-07-16 US US16/630,951 patent/US11278613B2/en not_active Expired - Fee Related
-
2022
- 2022-02-02 US US17/591,421 patent/US20220241398A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11998597B2 (en) | Vaccine against RSV | |
| JP7523897B2 (ja) | 呼吸器合胞体ウイルス（ｒｓｖ）ワクチン | |
| US11103578B2 (en) | Respiratory virus nucleic acid vaccines | |
| US11602557B2 (en) | Bunyavirales vaccine | |
| WO2022101469A1 (en) | Compositions and methods for stabilization of lipid nanoparticle mrna vaccines | |
| CN111526886A (zh) | 多基因流感疫苗 | |
| JP2013523096A5 (enExample) | ||
| JP2026509266A (ja) | 核酸インフルエンザワクチン及び呼吸器ウイルス混合ワクチン | |
| JP2024537250A (ja) | インフルエンザワクチン | |
| WO2023051701A1 (zh) | 抗SARS-CoV-2感染的mRNA、蛋白以及抗SARS-CoV-2感染的疫苗 | |
| JP2025516330A (ja) | 核酸ワクチンのシグナル配列 | |
| CN109923125B (zh) | 免疫原性组合物 | |
| CN120813371A (zh) | 用于在衣原体病的治疗中使用的组合物 | |
| CN116650633A (zh) | 冠状病毒疫苗 | |
| WO2025251934A1 (zh) | 一种抗肝癌hla-a11型疫苗及其制备方法和应用 | |
| JP7642608B2 (ja) | ハンタウイルス抗原性組成物 | |
| TW202539697A (zh) | 冠狀病毒疫苗 | |
| JP2026500282A (ja) | インフルエンザウイルス様粒子をコードするｍＲＮＡ | |
| EP3035960B1 (en) | Respiratory syncytial virus (rsv) vaccine | |
| US20250041400A1 (en) | Rsv vaccine | |
| HK40097472A (en) | Coronavirus vaccine | |
| WO2025250938A2 (en) | Respiratory syncytial virus and metapneumovirus vaccines | |
| WO2025251935A1 (zh) | 一种抗肝癌hla-a02型疫苗及其制备方法和应用 | |
| WO2025260633A1 (zh) | Rsv和hmpv融合f蛋白及其用途 | |
| JP2026065934A (ja) | Ｓｎａｒｅを活用しウイルスに対する液性免疫を誘導する核酸構築物 |